All In Biotech

Free tool

FAERS Monitor: Adderall Xr 10

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021303 or its brand name (Adderall Xr 10, Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate). Reports on generic versions are filed under their own applications.

Reports

41,907

Serious

18,198

43% of reports

Hospitalization

5,003

Death reported

515

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,838
  • fatigue3,271
  • nausea2,969
  • headache2,700
  • anxiety2,546
  • depression2,150
  • feeling abnormal2,034
  • pain1,805
  • dizziness1,792
  • somnolence1,743
  • insomnia1,642
  • off label use1,517
  • vomiting1,312
  • malaise1,192
  • weight decreased1,177

Reports by year received

View as table
YearReports
200436
200538
200725
20085
20097
201025
201163
2012374
2013892
20141,261
20153,395
20167,276
20173,081
20183,384
20193,220
20202,918
20212,302
20222,889
20233,054
20242,862
20252,860
20261,940

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,012,252 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
depressionSignal2,1504.84.66,428
anxietySignal2,5464.54.47,012
somnolenceSignal1,7434.44.24,537
feeling abnormalSignal2,0344.34.15,140
insomniaSignal1,6423.13.02,360
headacheSignal2,7002.22.11,739
weight decreasedSignal1,1772.12.0702
fatigueSignal3,2712.12.01,983
nausea2,9691.91.81,279
drug ineffective4,8381.81.81,991
dizziness1,7921.81.7657
pain1,8051.51.4284
vomiting1,3121.41.3154
malaise1,1921.41.3118
off label use1,5170.90.831

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.